Clinical Trials in New York

Showing 2301-2320 of 22,668 trials

A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease

NCT06753331

The Goal of this study is to evaluate the safety, tolerability, and clinical responses following implantation of DSP-1083. Study enrolls both male and female patients in 2 cohorts. This study will be held in approximately 5-8 study sites in United States

Parkinson's Disease

Sumitomo Pharma America, Inc.25 participantsStarted Dec 2024

Lexington, Kentucky, United States • New York, New York, United States

Active Not RecruitingPhase 1< 1 mile

A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors

NCT05307705

The main purpose of this study is to learn more about the safety, side effects, and effectiveness of LOXO-783. LOXO-783 may be used to treat breast cancer and other solid tumors that have a change in a particular gene (known as the PIK3CA gene). Participation could last up to 36 months (3 years) and possibly longer if the disease does not get worse.

Breast Cancer

Eli Lilly and Company193 participantsStarted May 2022

Scottsdale, Arizona, United States • Los Angeles, California, United States • San Francisco, California, United States +47 more locations

A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease

A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors

Find Trials by Condition in New York

Cardiopulmonary Outcomes in Osteogenesis Imperfecta: BBD7708

Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC

Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation

Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer

LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA)

Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

A Study of Pembrolizumab With Lenvatinib in Women With Advanced Uterine Carcinosarcoma

Safety and Efficacy of Combined EMS and RF Treatments

A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies

A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)

REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors

Open-Label Extension of EryDex Study IEDAT-04-2022

A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With Cemiplimab or REGN5678 for Adult Participants With Advanced Prostate Cancer

Oral N-acetylcysteine for Retinitis Pigmentosa

GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease

A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

A Study to Compare Safety and Efficacy of High Doses of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON)

Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults 50 Years of Age or Older (V116-010, STRIDE-10)